Notice of convocation of the Extraordinary General Shareholders Meeting and documents related to the Extraordinary General Meeting

Current report No. 5/2025

Date of preparation: 28 January 2025

Subject: Notice of convocation of the Extraordinary General Shareholders Meeting and documents related to the Extraordinary General Meeting

Legal basis: Article 56 sec. 1 point 2 of the Public Offering Act – current and periodical information

The Management Board of Captor Therapeutics S.A., based in Wrocław (the "Company"), pursuant to Article 398, Article 399 § 1 in connection with Articles 402¹ and 402² of the Commercial Companies Code, informs that the Extraordinary General Meeting of the Company was convened for 24 February 2025, at 2:00 P.M. and will be held in Wrocław at ul. Duńska 9 (54-427 Wrocław), in the DELTA building.

The Management Board of the Company encloses the following to this report:

1. the full text of the notice with the agenda of the Extraordinary General Meeting (appendix no. 1);

2. draft resolutions to be discussed at the Extraordinary General Meeting of the Company (appendix
no. 2);

3. specimen power of attorney (appendix no. 3);

4. specimen instruction to exercise voting rights by proxy (appendix no. 4);

5. information on the total number of votes (appendix no. 5).